Menu
Home
Forums
Forums
Quick Links
Search Forums
Recent Posts
job listings
catering
whistleblower info
legal help
advertise on CP
submit press release
Menu
Log in
Sign up
Search titles only
Posted by Member:
Separate names with a comma.
Newer Than:
Search this thread only
Search this forum only
Display results as threads
More...
Useful Searches
Recent Posts
Cafepharma Message Boards | Pharma Sales, Device Sales, Lab Sales
Home
Forums
>
Pharma/Biotech Companies
>
New Haven Pharmaceuticals
>
Dulaza Sold - Good Luck!
>
Reply to Thread
Name:
Verification:
Answer the above question:
(
CustomImgCaptcha
By
Surrey Forum
)
Message:
<p>[QUOTE="anonymous, post: 5819484"]<font size="5"><b>Espero Acquires DURLAZA® (aspirin) Extended Release Capsules for Secondary Prevention of Stroke and Acute Cardiac Events</b></font></p><p>February 7, 2017/ <a href="http://esperopharma.com/category/press-release/" target="_blank" class="externalLink ProxyLink" data-proxy-href="http://esperopharma.com/category/press-release/" rel="nofollow">Press Release</a></p><p><br /></p><p>JACKSONVILLE, Fla. (February 7, 2017) – Espero Pharmaceuticals, Inc., a commercial-stage cardiovascular pharmaceutical company, today announced that the company has acquired the global rights to DURLAZA® (aspirin) Extended Release Capsules.Company officials will provide an update on February 13, 2017 at the BIO CEO & Investor Conference held at the Waldorf Astoria New York. DURLAZA is an FDA-approved and commercially available prescription 24-hour extended-release aspirin capsule, the first and only once-daily drug of its kind, indicated for the secondary treatment of stroke and acute cardiac events. Approved in September 2015, DURLAZA is designed to reduce the risk of death and myocardial infarction in patients with chronic coronary artery disease, and reduce the risk of death and recurrent stroke in patients who have had an ischemic stroke or transient ischemic attack (TIA). <a href="http://www.durlaza.com/" target="_blank" class="externalLink ProxyLink" data-proxy-href="http://www.durlaza.com/" rel="nofollow">www.durlaza.com</a>[/QUOTE]</p><p><br /></p>
[QUOTE="anonymous, post: 5819484"][SIZE=5][B]Espero Acquires DURLAZA® (aspirin) Extended Release Capsules for Secondary Prevention of Stroke and Acute Cardiac Events[/B][/SIZE] February 7, 2017/ [URL='http://esperopharma.com/category/press-release/']Press Release[/URL] JACKSONVILLE, Fla. (February 7, 2017) – Espero Pharmaceuticals, Inc., a commercial-stage cardiovascular pharmaceutical company, today announced that the company has acquired the global rights to DURLAZA® (aspirin) Extended Release Capsules.Company officials will provide an update on February 13, 2017 at the BIO CEO & Investor Conference held at the Waldorf Astoria New York. DURLAZA is an FDA-approved and commercially available prescription 24-hour extended-release aspirin capsule, the first and only once-daily drug of its kind, indicated for the secondary treatment of stroke and acute cardiac events. Approved in September 2015, DURLAZA is designed to reduce the risk of death and myocardial infarction in patients with chronic coronary artery disease, and reduce the risk of death and recurrent stroke in patients who have had an ischemic stroke or transient ischemic attack (TIA). [URL='http://www.durlaza.com/']www.durlaza.com[/URL][/QUOTE]
Your name or email address:
Do you already have an account?
No, create an account now.
Yes, my password is:
Forgot your password?
Stay logged in
Cafepharma Message Boards | Pharma Sales, Device Sales, Lab Sales
Home
Forums
>
Pharma/Biotech Companies
>
New Haven Pharmaceuticals
>
Dulaza Sold - Good Luck!
>
Cafepharma Message Boards | Pharma Sales, Device Sales, Lab Sales
Home
Forums
>
Pharma/Biotech Companies
>
New Haven Pharmaceuticals
>
Dulaza Sold - Good Luck!
>